Answers are grounded in this paper and cite their sources.
Blast Overpressure (BOP) inflicts severe immediate physical and continuous inflammatory injury upon air/gas filled-hollow organs, i.e., lungs and intestines. Sprague-Dawley rats were subjected to BOP (120 kilopascals) to study military relevant injuries. Recombinant human DAF (rhDAF) was administered (50g/kg body weight) 30 minutes post-blast to simulate expected emergency care chronology. The rhDAF treatment group was compared to 1) sham control group-no BOP exposure with no saline injection, and 2) BOP with saline injection group (30 minutes post-blast). Within each group, animals underwent recovery (simulated or veritable) and were sacrificed at 3, 24 and 48 hours post-blast. Lung and small intestine tissue samples were prepared for pathology injury assessments, microscopic evaluations and immunohistochemistry assessment of tissue marker deposition (rhDAF, complement C5, Neutrophil Elastase (NE), and caspase-1). BOP resulted in pulmonary and intestinal damage that was mitigated by post-blast administration of rhDAF. Complement activator C5/C5a, NE, and caspase-1 increased during 3 to 48 hours following BOP. rhDAF treatment significantly reduced levels of C5/C5a, and NE after their induction, but did not alter caspase-1 levels. These novel findings suggest early complement inhibition via rhDAF administration is a promising new therapeutic strategy to decrease BOP-induced pulmonary and intestinal tissue injury.
No takes yet. Share an insight, caveat, or question.
Jurandir J. Dalle Lucca (2017) studied this question.
Synapse has enriched 4 related papers. Consider them for comparative context: